Paul Schaper leads global policy efforts at ‎Merck Sharp & Dohme on infectious diseases, including antibiotics/antifungals, HIV and hepatitis. Since 2013, he has served as the private sector representative on the board of the Global Fund for HIV, TB and Malaria. Schaper earned his B.A. and master’s degrees in public health policy and business administration from Emory University and another master’s degree in clinical psychology from Georgia State University.